A Study to Confirm Safe Intake of L-Leucine, L-Valine, L-Isoleucine, and L-Threonine in Healthy Adults - A Randomized, Double-Blind, Placebo-Controlled Trial(AJI-2022VLIT-S1)

Miura Naoki0 个研究点目标入组 120 人开始时间: 2023年11月25日最近更新: 2024年4月1日

适应症

试验速览

暂无简介。

•1) Healthy male aged between 20 and 60 years at the time of informed consent.
•2) Subjects who have fully understood the purpose and content of this research after receiving a sufficient explanation about participating in the research, and who have given their voluntary written consent.

•1) Are taking or are likely to take pharmaceuticals on an ongoing basis during the period of consumption of the test food.
•2) Is taking or will take a supplement containing amino acids as a major component from the time of study entry until the end of the test food intake period.
•3) Are currently participating in another human study as a study subject, have participated in another human study within 4 weeks of the completion of the study, or plan to participate in another human study during the study period.
•4) Any of the following
•(1) Persons with heart, liver, or kidney disease (including complications from other diseases)
•(2) Persons with respiratory system diseases
•(3) Those with a history of cardiovascular disease
•(4) Those who have diabetes mellitus
•(5) Those who have intestinal disease
•(6) Those who have heavy burden of cancer, tuberculosis, etc.Those who are under treatment for or have a history of serious diseases such as cancer and tuberculosis
•(7) Those with congenital metabolic disorders of branched-chain amino acids
•5) Subjects with allergies to medicinal products or food
•6) Other subjects who are judged by the investigator to be unsuitable for the study

发起方

Miura Naoki